Clinical Trials on Adult Primary Hepatocellular Carcinoma in Netherlands

Total 269 results

St. Antonius Hospital
Merck Sharp & Dohme LLC

Recruiting

A Prospective Study to Evaluate the Implementation of Shared Decision Making Strategy for Renal Cell Cancer (RCC) (SDM-RCC)

Renal Cell Carcinoma | Renal Cell Carcinoma Metastatic

Netherlands
Academisch Medisch Centrum - Universiteit van Amsterdam...

Unknown

Efficacy and Safety of IRE for RMs

Kidney Cancer

Netherlands
Academisch Medisch Centrum - Universiteit van Amsterdam...

Unknown

Optical Biopsy to Improve the Diagnosis of Kidney Cancer

Kidney Cancer

Netherlands
Radboud University Medical Center

Completed

Study of the Immunoresponse in Patients Treated With a Tyrosine Kinase Inhibitor

Renal Cell Carcinoma | GIST

Netherlands
Academisch Medisch Centrum - Universiteit van Amsterdam...

Unknown

Contrast Ultrasound Dispersion Imaging (CUDI) as a Diagnostic Modality in the Diagnosis of Renal Cell Carcinoma (CUDI-RCC)

Kidney Cancer

Netherlands
Academisch Medisch Centrum - Universiteit van Amsterdam...

Completed

Study of Nelfinavir and Temsirolimus in Patients With Advanced Cancers (I-NET)

Cancer | Renal Cell Cancer

Netherlands
University Medical Center Groningen

Completed

VEGF Imaging in Renal Cell Carcinoma (Renimage)

Renal Cell Carcinoma

Netherlands
Radboud University Medical Center
Novo Nordisk A/S

Completed

Influence of Sutent on Tumor Vascularization and Necrosis in Patients With Renal Cell Carcinoma

Renal Cell Cancer

Netherlands
University Medical Center Groningen

Not yet recruiting

OPTI - DOSE: Optimal Dosing of Oral Anticancer Drugs in Older Adults (OPTI-DOSE)

Renal Cell Carcinoma | Breast Carcinoma | Thyroid Carcinoma | Ovarian Carcinoma | Endometrium Carcinoma

Netherlands
University of Birmingham
University of Oslo; The Leeds Teaching Hospitals NHS Trust; University of Padova and other collaborators

Active, not recruiting

Paediatric Hepatic International Tumour Trial (PHITT)

Carcinoma, Hepatocellular | Hepatoblastoma

United Kingdom, France, Austria, Israel, Spain, Belgium, Czechia, Finland, Germany, Ireland, Netherlands, Norway, Poland, Switzerland
DeuterOncology

Recruiting

Study to Determine the Safety and Pharmacokinetics of DO-2 in Patients With Advanced or Refractory Solid Tumours

Adult Solid Tumor | Lung Cancer | Advanced Solid Tumor | Non-small Cell Lung Cancer | Non-small Cell Carcinoma | Refractory Tumor | Hereditary Renal Papillary Cancer

France, Belgium, Netherlands
Haaglanden Medical Centre
Tata Memorial Centre

Not yet recruiting

Towards Optimal Treatment for High Risk Prostate Cancer (HYPOPRIME)

High Risk Prostate Carcinoma

Netherlands
Nucleix Ltd.

Completed

Utility of Bladder EpiCheck for Detection of Recurrent Urothelial Carcinoma

Bladder Cancer

Netherlands, Israel, Germany, Spain
Radboud University Medical Center

Completed

Lean Body Mass as a Determinant of Docetaxel Pharmacokinetics and Toxicity (LEANDOC)

Breast Cancer | Metastatic Castration-resistant Prostate Carcinoma

Netherlands
The Netherlands Cancer Institute
Bristol-Myers Squibb

Recruiting

Neoadjuvant Study With Combination Immuno-oncology for Primary Clear Cell Renal Cell Cancer (NESCIO)

Renal Cell Carcinoma

United Kingdom, Netherlands
Radboud University Medical Center
Dutch Cancer Society

Completed

The Vascular and Metabolic Effects of Sunitinib in Patients With Metastatic Renal Cell Carcinoma

Renal Cell Carcinoma | Hypertension | Insulin Sensitivity | Renal Function

Netherlands
Sanofi
Merck Sharp & Dohme LLC

Active, not recruiting

A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Gastrointestinal Cancer (Master Protocol) (Pegathor Gastrointestinal 203)

Hepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | Oesophageal Adenocarcinoma | Oesophageal Squamous Cell Carcinoma

Korea, Republic of, Belgium, Italy, United States, Chile, China, France, Netherlands, Spain
Radboud University Medical Center

Unknown

Temsirolimus-RCC-imaging

Renal Cell Cancer

Netherlands
European Organisation for Research and Treatment...

Completed

SCH 66336 Plus Gemcitabine in Treating Patients With Advanced Cancer of the Urinary Tract

Bladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral Cancer

Netherlands
M. Labots

Terminated

Prediction of Response to Kinase Inhibitors Based on Protein Phosphorylation Profiles in Tumor Tissue From Advanced Renal Cell Cancer Patients

Renal Cell Cancer

Netherlands
Novo Nordisk A/S

Completed

Combination of Recombinant Human IL-21 (rIL-21) and Sunitinib in Stage IV Renal Cell Carcinoma Patients

Renal Cell Carcinoma | Cancer

Germany, Netherlands
dr. Tom van der Hulle
Leiden University Medical Center

Recruiting

The Pharmacological Effects of Using Cabozantinib With a Light Breakfast (Skippy 1)

Renal Cell Carcinoma

Netherlands
Radboud University Medical Center

Completed

Evaluation of Cognitive Function of Patients With Sunitinib or Sorafenib

Metastatic Renal Cell Cancer | GIST

Netherlands
Radboud University Medical Center

Unknown

Study to the Optimal Duration of Therapy With Oral Angiogenesis Inhibitors

Renal Cell Carcinoma | Gastrointestinal Stromal Tumor

Netherlands
Bayer

Completed

Study of Regorafenib After Sorafenib in Patients With Hepatocellular Carcinoma (RESORCE)

Carcinoma, Hepatocellular

France, Spain, China, Switzerland, United States, Singapore, Germany, Russian Federation, Taiwan, Austria, Czechia, United Kingdom, Korea, Republic of, Australia, Hungary, Italy, Netherlands, Japan, Belgium, Brazil, Argentina
University Medical Center Groningen
Mendus

Recruiting

Phase 1 Study to Evaluate the Safety, Feasibility and Immunogenicity of an Allogeneic, Cell-based Vaccine (DCP-001) in High Grade Serous Ovarian Cancer Patients After Primary Treatment (ALISON)

Ovarian Cancer

Netherlands
The Netherlands Cancer Institute

Unknown

Clinical Impact of Dedicated MR Staging of Ovarian Cancer (MRStagingOC)

Ovarian Cancer

Netherlands
University Medical Center Groningen
ISA Pharmaceuticals B.V.; Dutch Cancer Society

Completed

p53 Synthetic Long Peptides Vaccine With Cyclophosphamide for Ovarian Cancer (ISA-P53-CTX)

Ovarian Cancer

Netherlands
Leiden University Medical Center

Recruiting

Determining Prognostic Immune Markers in Patients With Ovarian Cancer (IMPrOVE)

Epithelial Ovarian Cancer

Netherlands
Leiden University Medical Center
University Medical Center Groningen

Completed

Chemo-immunotherapy (Gemcitabine, Interferon-alpha 2b and p53 SLP) in Patients With Platinum-resistant Ovarian Cancer (CHIP)

Recurrent Ovarian Cancer

Netherlands
GlaxoSmithKline

Completed

Study Of Safety And Tolerability Of GW786034 Given With Lapatinib In Cancer Patients

Carcinoma, Renal Cell

United States, Netherlands
Radboud University Medical Center

Recruiting

NEOadjuvant Dendritic Cell Vaccination for Ovarian Cancer (NEODOC)

Epithelial Ovarian Cancer | Ovarian Carcinoma

Netherlands
Maastricht University Medical Center
Erasmus Medical Center; Jules Bordet Institute; Academisch Ziekenhuis Maastricht

Recruiting

Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI

Unspecified Adult Solid Tumor, Protocol Specific

Netherlands, Belgium
The Netherlands Cancer Institute
Bristol-Myers Squibb

Active, not recruiting

Checkpoint Inhibition and Chemoradiotherapy as Bladder Sparing Treatment in UC (Indi-Blade)

Bladder Cancer | Urothelial Carcinoma

Netherlands
Queen Mary University of London
Hoffmann-La Roche

Unknown

Preoperative MPDL3280A in Transitional Cell Carcinoma of the Bladder (ABACUS)

Bladder Cancer

United Kingdom, France, Spain, Netherlands
Maastricht University Medical Center

Completed

Sentinel Node Detection in Clinical Early Stage Ovarian Cancer (SONAR)

Ovarian Cancer | Sentinel Node

Netherlands
University Medical Center Groningen

Terminated

Long Term Survivors in Ovarian Cancer

Ovarian Cancer

Netherlands
Gynaecologisch Oncologisch Centrum Zuid
Radboud University Medical Center; Maastricht University Medical Center; Erasmus... and other collaborators

Recruiting

Signal TrAnsduction Pathway Activity Analysis in OVarian cancER (STAPOVER)

Recurrent Ovarian Cancer | Therapy-Associated Cancer | Signal Transduction Pathway Deregulation

Netherlands
Leiden University Medical Center
University Medical Center Groningen

Completed

Feasibility of the Combination of Chemotherapy (Carbo/Caelyx or Carbo/Doxorubicin) With Tocilizumab (mAb IL-6R) and Peg-Intron in Patients With Recurrent Ovarian Cancer (PITCH)

Recurrent Ovarian Cancer

Netherlands
Maastricht University Medical Center
VieCuri Medical Centre; Orbis Medical Centre; St.Jans Gasthuis Weert; Laurentius...

Terminated

Study Into a New Diagnostic Tool (Simple Ultrasound-based Rules) in Patients With Adnexal Masses (SUBSONiC)

Ovarian Cancer | Ovarian Carcinoma | Ovarian Cyst | Ovarian Mass

Netherlands
University Medical Center Groningen

Completed

Study of Metformin With Carboplatin/Paclitaxel Chemotherapy in Patients With Advanced Ovarian Cancer (OVMET)

Epithelial Ovarian Cancer

Netherlands
Leiden University Medical Center

Recruiting

Adoptive T Cell Therapy in Patients With Recurrent Ovarian Cancer (OVACURE)

Ovarian Cancer Recurrent

Netherlands
Merck Sharp & Dohme LLC
Eisai Inc.

Active, not recruiting

Safety and Efficacy of Lenvatinib (E7080/MK-7902) With Pembrolizumab (MK-3475) in Combination With Transarterial Chemoembolization (TACE) in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma (MK-7902-012/E7080-G000-318/LEAP-012)

Carcinoma, Hepatocellular

Colombia, Israel, Taiwan, United States, Australia, Brazil, Chile, China, Denmark, France, Germany, Hong Kong, Hungary, Ireland, Italy, Japan, Korea, Republic of, Netherlands, New Zealand, Norway, Portugal, Puerto Rico, Spain, Thailand, Turke... and more
University Medical Center Groningen
Dutch Cancer Society; ViciniVax B.V

Recruiting

Vvax001 Cancer Vaccine in Premalignant Cervical Lesions - Phase II (Vvax)

Cervical Intraepithelial Neoplasia | CIN3 | Cervical Intraepithelial Neoplasia Grade 3 | HPV 16 Infection

Netherlands
University Medical Center Groningen
BioNTech SE

Terminated

Ovarian Cancer Treatment With a Liposome Formulated mRNA Vaccine in Combination With (Neo-)Adjuvant Chemotherapy (OLIVIA)

Ovarian Cancer

Netherlands
The Netherlands Cancer Institute

Recruiting

Body Surface Area-based vs Concentration-based Dosing of Cisplatin for Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Women With Advanced Ovarian Cancer (CisCon)

Fallopian Tube Carcinoma | Peritoneal Cancer | FIGO Stage III Ovarian Cancer

Netherlands
AstraZeneca

Completed

Cediranib (AZD2171, RECENTIN™) in Metastatic or Recurrent Renal Cell Carcinoma

Renal Cell Carcinoma

United Kingdom, Netherlands
Academisch Medisch Centrum - Universiteit van Amsterdam...
Merck Sharp & Dohme LLC; PTC Therapeutics

Recruiting

Pembrolizumab With Ataluren in Patients With Metastatic pMMR and dMMR Colorectal Carcinoma or Metastatic dMMR Endometrial Carcinoma: the ATAPEMBRO Study (ATAPEMBRO)

Colorectal Cancer | Endometrium Cancer

Netherlands
Maastricht University Medical Center
Universitaire Ziekenhuizen KU Leuven

Not yet recruiting

Magtrial: Magtrace® as Tracer for Sentinel Lymph Node Detection in Early Stage Epithelial Ovarian Cancer

Ovarian Cancer | Lymph Node Metastasis

Netherlands
University Medical Center Groningen

Completed

FES-PET to Determine ER-expression in Epithelial Ovarian Cancer

Epithelial Ovarian Cancer

Netherlands

Clinical Trials on Adult Primary Hepatocellular Carcinoma in Netherlands

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bulgaria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations